Invesco Ltd. Sells 198,471 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Invesco Ltd. has reduced its stake in Bath & Body Works by 27.9% during the first quarter, now holding 513,193 shares valued at approximately $15.56 million.
• Analysts have mixed outlooks, with Goldman Sachs lowering its target price from $44.00 to $43.00, while JPMorgan Chase & Co. increased its target from $40.00 to $46.00 and gave it an "overweight" rating.
• Bath & Body Works announced a quarterly dividend of $0.20 per share, translating to an annualized yield of 2.6%, with a payout ratio of 21.33%.

Invesco Ltd. trimmed its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 27.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 513,193 shares of the company's stock after selling 198,471 shares during the quarter. Invesco Ltd. owned approximately 0.24% of Bath & Body Works worth $15,560,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Bath & Body Works by 38.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after buying an additional 11,681 shares during the period. Kovitz Investment Group Partners LLC acquired a new position in shares of Bath & Body Works in the fourth quarter worth about $258,000. Merit Financial Group LLC acquired a new position in shares of Bath & Body Works in the first quarter worth about $714,000. Nuveen Asset Management LLC boosted its holdings in shares of Bath & Body Works by 3.7% in the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after buying an additional 27,136 shares during the period. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after buying an additional 1,606,988 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. The Goldman Sachs Group decreased their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Barclays decreased their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. Finally, Morgan Stanley decreased their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus price target of $42.53.

Bath & Body Works Price Performance

BBWI traded down $2.08 during midday trading on Thursday, hitting $29.47. 17,266,529 shares of the company's stock traded hands, compared to its average volume of 4,970,217. The company has a market cap of $6.24 billion, a PE ratio of 7.86, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54. The stock's fifty day simple moving average is $30.61 and its 200-day simple moving average is $30.86. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company's revenue for the quarter was down .8% on a year-over-year basis. During the same quarter last year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, August 22nd. Bath & Body Works's dividend payout ratio is 21.33%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.